Evidence map›Paper›PMID 32050501›Full record

ArticleJournal of clinical medicine2020

Clinical Performance of Zygomatic Implants-Retrospective Multicenter Study.

Ruben Davó, Simonas Bankauskas, Remigijus Laurincikas, Ismail Doruk Koçyigit, José Eduardo Mate Sanchez de Val

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07258940 (A 1-year Prospective Multicenter Clinical Investigation to Assess Safety, Performance and Clinical Benefits of the NobelZygoma TiUltra Implant System in the Rehabilitation of Severely Atrophic Maxillae), which is not on this map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07258940 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A 1-year Prospective Multicenter Clinical Investigation to Assess Safety, Performance and Clinical Benefits of the NobelZygoma TiUltra Implant System in the Rehabilitation of Severely Atrophic Maxillae

TypeinterventionalSponsorNobel BiocareRan2026 to 2029Enrolled85ConditionsEdentulous Maxilla, Maxillary Bone Loss, Atrophic MaxillaArmsNobelZygoma™ 0° CC TiUltra™implant, NobelZygoma™ 45° Ext Hex TiUltra™ implant, Multi-Unit Abutment Xeal Zygoma Ext Hex RP, 17° Multi-Unit Abutment Xeal Zygoma Ext Hex RP, 45° Multi.Unit Abutment Xeal Zygoma CC RP
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Rehabilitating Patients with Atrophic Maxillae via Zygomatic Implants.Clinical, cosmetic and investigational dentistry · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Ruben DavóInstituto Davó, 03026 Alicante, Spain.
Simonas BankauskasUAB "SB dantuklinika", LT49452 Kaunas, Lithuania.
Remigijus LaurincikasUAB "SB dantuklinika", LT49452 Kaunas, Lithuania.
Ismail Doruk KoçyigitKirikkale University, Dentistry Faculty, Department of Oral & Maxillofacial Surgery, 71450 Kirikkale, Turkey.
José Eduardo Mate Sanchez de ValInstituto Davó, 03026 Alicante, Spain.

Funding

Nobel Biocare Services AG 2017-1509
6 · The paper itself

Abstract

The main objective of this analysis was to evaluate (1) implant survival, (2) biologic complications, and (3) demographics associated with zygomatic implants placed according to the zygomatic anatomy-guided approach (ZAGA). This retrospective multicenter study reviewed data from the charts of 82 consecutive patients who had received 182 zygomatic implants. Patients were fully edentulous (62.2%), partially edentulous (22.0%), or had failing dentition (15.9%). Most patients (87.5%) did not have previous sinusitis and 11.3% had been previously treated for it. Additionally, about half of the patients (53.8%) did not present periodontal pathology, and one-third (36.3%) did, but were subsequently treated. Most implants (93.8%) were loaded immediately, i.e., within 48 h of placement. Implants were followed for 10.5 ± 7.2 months, and all were recorded as surviving and stable at last follow-up. Post-operative complications were infrequent and included sinusitis (10.1%) and peri-implant hyperplasia (0.8%). The low complication rate and 100% implant survival and stability indicate that zygomatic implants offer a viable treatment option when performing graftless restoration of severely resorbed maxilla, including immediate loading protocols.

Indexed as

edentulousresorbed maxillazygomatic implant

Identifiers

PMID32050501
PMCPMC7074322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.